Consolidated Statements of Loss and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
Research and development expenses, net of government assistance	$ (4,683)	$ (9,972)
General and administrative expenses	(6,432)	(7,614)
Sales and marketing	(252)	(661)
Restructuring cost	(1,485)	0
Impairment of intangible assets	0	(28,682)
Impairment of goodwill	0	(4,826)
Impairment of assets held for sale	0	(400)
Loss from operating activities	(12,852)	(52,155)
Foreign exchange loss	(16)	(72)
Change in fair value of warrant liabilities	(2,728)	10
Interest income and other expense, net	911	246
Total other income (expense), net	(1,833)	184
Loss before income tax benefit	(14,685)	(51,971)
Income tax benefit	1,832	9,542
Net loss and total comprehensive loss	$ (12,853)	$ (42,429)
Earnings Per Share Basic	$ (1.35)	$ (5.71)
Earnings Per Share Diluted	$ (1.35)	$ (5.71)
Weighted Average Number Of Shares Outstanding Basic	9,529,123	7,435,472
Weighted Average Number Of Shares Outstanding Diluted	9,529,123	7,435,472